Simulation of platelet adhesion and aggregation regulated by fibrinogen and von Willebrand factor

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH07-08-0490
Issue:2008: 99/1 (Jan) pp. 1-248
Pages:108-115

Simulation of platelet adhesion and aggregation regulated by fibrinogen and von Willebrand factor

Daisuke Mori1, Koichiro Yano2, Ken-ichi Tsubota3, Takuji Ishikawa1, Shigeo Wada4, Takami Yamaguchi1
1Deptartment of Bioengineering and Robotics, Tohoku University, Japan; 2Toyota Motor Corporation, Japan; 3Department of Electronics and Mechanical Engineering, Chiba University, Japan; 4Department of Mechanical Science and Bioengineering, Osaka University, Japan

Summary

We propose a method to analyze platelet adhesion and aggregation computationally, taking into account the distinct properties of two plasma proteins, vonWillebrand factor (vWF) and fibrinogen (Fbg). In this method, the hydrodynamic interactions between platelet particles under simple shear flow were simulated using Stokesian dynamics based on the additivity of velocities. The binding force between particles mediated by vWF and Fbg was modeled using the Voigt model.Two Voigt models with different properties were introduced to consider the distinct behaviors of vWF and Fbg. Our results qualitatively agreed with the general observation of a previous in-vitro experiment, thus demonstrating that the significant development of thrombus formation in height requires not only vWF, but also Fbg. This agreement of simulation and experimental results qualitatively validates our model and suggests that consideration of the distinct roles of vWF and Fbg is essential to investigate the physiological and pathophysiological mechanisms of thrombus formation using a computational approach.

Keywords

thrombus, Computational simulation, glycoprotein receptors, shear flow

DOI

http://dx.doi.org/10.1160/TH07-08-0490

You may also be interested in...

1.

- See additional videos by clicking on [Summary] -

Marijke J. E. Kuijpers1, Miroslava Pozgajova3, Judith M. E. M. Cosemans1,2, Imke C. A. Munnix1, Beate Eckes4, Bernhard Nieswandt3, Johan W. M. Heemskerk1,2

Thrombosis and Haemostasis 2007 98 5: 1072-1080

http://dx.doi.org/10.1160/TH07-02-0089

2.

Maggie Folkesson1*, Monsur Kazi1,2*, Chaoyong Zhu2, Angela Silveira2, Anne-Louise Hemdahl3, Anders Hamsten2, Ulf Hedin1, Jesper Swedenborg1, Per Eriksson2

Thrombosis and Haemostasis 2007 98 2: 427-433

http://dx.doi.org/10.1160/TH06-11-0638

3.

Online Supplementary Material

D. W. S. Harty (1), R. M. Farahani (1, 2), M. R. Simonian (1), L. Hunter (3), N. Hunter (1, 2)

Thrombosis and Haemostasis 2012 108: -

http://dx.doi.org/10.1160/TH12-01-0032



Articles

You've 264 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...